Navigating the path to new therapies, experimental drug sales involve the legal distribution of investigational medications outside of clinical trials. Used primarily through expanded access programs, this process allows patients with serious or life-threatening conditions to try unapproved treatments when no alternatives exist. The primary beneficiaries are those who have exhausted standard options, offering a potential lifeline while contributing valuable real-world data to ongoing research.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends